Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.8100
-0.0030 (-0.37%)
Mar 31, 2025, 2:04 PM EDT - Market open
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $7.19 million as of March 31, 2025. Its market cap has decreased by -13.35% in one year.
Market Cap
7.19M
Enterprise Value
6.22M
1-Year Change
-13.35%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $7.19M, a decrease of -79.63%. That is a compound annual growth rate of -37.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 7.21M | -14.59% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |